Trending

In-depth Analysis of Postpartum Depression Drug Market 2020: Competitive Growth, Trends, Share

Postpartum depression (PPD), also known as postnatal depression, is a type of mood disorder that results post pregnancy. Signs of depression include, insomnia, fatigue and sadness, loss of appetite, mood swings, anxiety, and anger. Hormonal changes such as elevated prolactin levels, depleted oxytocin and thyroid hormone levels can be a cause of PPD in females.

Increasing research activities for treatment of PPD is expected to propel growth of the postpartum depression drug market during the forecast period. For instance, Sage Therapeutics is undergoing phase 3 clinical study for the drug —Brexanolone, which might be useful in the treatment of PPD. The study started in May 2018 and is estimated to be completed in September 2020.

Furthermore, Marinus Pharmaceuticals, is undergoing clinical phase 2 study for the drug Ganaxolone in the treatment of PPD and other mood associated disorders. The clinical study started in June 2017 and is expected to be completed in June 2019.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2258

The total market is further segmented based on company, country, and application/type for competitive landscape analysis. On the contrary, information on industry chain structure, emerging applications, and technological developments in the market makes the report a must-read document.

These insights help determine the strength of competition and take the necessary steps to obtain a leading position in the “Postpartum Depression Drug.” industry.

The market can be segmented into:

By Drug Class

  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
  • Tricyclic Antidepressants
  • Atypical Antidepressants
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Key players operating in the global postpartum depression drug market include, Sage Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Intas Pharmaceuticals Ltd., Mylan N.V., Anikem Laboratories, and Shionogi & Co., Ltd.

LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount for Buyers UPTO 30% OFF On Any Research Report

Buy Now with Discount for Premium Report : https://www.coherentmarketinsights.com/insight/buy-now/2258

The chapters covered in the research report are as follows:

Chapter 1, 2: Targets of the Global Postpartum Depression Drug Market, encompassing market introduction, product images, market summary, and development scope.

Chapter 3, Chapter 4: Global Market Competition, Sales Volume, and Market Profit by Manufacturer.

Chapters 5, 6, 7: Global Supply (Production), Consumption, Exports, Imports by Regions such as USA, Asia Pacific, China, India, Japan. From 2015 to 2024, we conduct regional market research based on regional sales rate and market share.

Chapters 8, 9, 10: Global Market Analysis by Application, Cost Analysis, Marketing Strategy Analysis, Distributor/Trader

Chapters 11, 12: Market Information and Research Conclusions, Appendix and Data Sources.

In addition, the research report investigates:

Competitors and manufacturers in the global market

By product type, application and growth factor

Industry status and outlook for major applications / end users / usage areas

Request For PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2258

Thanks for reading this article. You can also get individual chapter sections, such as North America, Europe, or Asia, or regional versions of the report.

Contact us:

Mr. Shah
Senior Client Partner – Business Development
sales@coherentmarketinsights.com
www.coherentmarketinsights.com

Back to top button